Physician profile
Violet K Hunter
NPI 1811348956
$789.15
in general payments reported to CMS, 2019-2025
16 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2022: $61.64 · 2023: $166 · 2024: $232 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.95 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $125.55 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $121.66 | 2023-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $81.40 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Inari Medical, INC. | $61.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $53.65 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $39.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.39 | 2024 | Farxiga, Breztri |
| Amgen INC. | $29.87 | 2023-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $29.33 | 2019 | |
| Exact Sciences Corporation | $15.36 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.66 | 2023 | Verquvo |
| Otsuka America Pharmaceutical, INC. | $14.62 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $13.14 | 2023 | Trelegy Ellipta |
| Allergan, INC. | $12.73 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $6.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Violet Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.